Home/ Stocks/ AEMD

AETHLON MEDICAL INC

AEMD XNAS

$1.36 +0.00 (+0.00%) ▲ 15-min delayed

Open

$1.38

High

$1.43

Low

$1.35

Volume

141.0K

Market Cap

$4.48M

About AETHLON MEDICAL INC

Aethlon Medical Inc is a medical therapeutic company focused on developing the Hemopurifier (HP), a clinical-stage investigational immunotherapeutic device designed to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation and other disease states in which extracellular vesicles (EVs) contribute to disease progression. The Hemopurifier utilizes a proprietary lectin-based technology to bind and remove enveloped viruses and EVs from biological fluids. EVs have been associated with immune suppression, metastasis, and resistance to therapy in cancer, as well as progression of severe infectious diseases. The Company operates as a single reportable segment.

Sector: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS Employees: 9 Website →

Key Financials

Period	Revenue	Net Income	EPS
TTM 2026	$0	$-7,151,469	$-10.61
FY 2026	$0	$-7,151,469	$-10.61
Q3 2026	$43.9K	$-2,018,245	$-2.45
Q2 2026	$22.7K	$-1,487,100	$-3.74

Earnings & Analyst Ratings

Next Earnings: Tue, Aug 11, 2026

Calendar →

Related Market News

No specific coverage for AEMD yet. Check out our latest market news or earnings calendar.

Get AEMD Alerts

Stay ahead with breaking news, price alerts, and expert analysis on AETHLON MEDICAL INC.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.